Ivana Vaněčkova
3PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Oct 27, 2022
Empagliflozin Is Not Renoprotective in Non-Diabetic Rat Models of Chronic Kidney Disease.Silvie Hojná, Zoe Kotsaridou, Zdeňka Vaňourková
|Sep 23, 2022
Beneficial Effects of Empagliflozin Are Mediated by Reduced Renal Inflammation and Oxidative Stress in Spontaneously Hypertensive Rats Expressing Human C-Reactive Protein.Hana Malínská, Martina Hüttl, Irena Marková
|Nov 13, 2021
In a Prediabetic Model, Empagliflozin Improves Hepatic Lipid Metabolism Independently of Obesity and before Onset of Hyperglycemia.Martina Hüttl, Irena Markova, Denisa Miklankova
Pageof 1
